The short answer: For the deep half of the work, analyzing an announced or likely deal between public companies, AllMind AI is the system built for it: both sides sit on one map carrying their filings, S&P and FactSet fundamentals, LSEG estimates, expert calls, entitled broker research and the supplier and customer links that decide the antitrust read, with your own target tracker and models joined to all of it. To build a private target universe the deal databases still lead: Grata for founder-owned companies, PitchBook and S&P Capital IQ for sponsor-backed names and precedents, Mergermarket for who is about to sell. Hebbia handles data-room diligence, Rogo produces banker deliverables, AlphaSense carries the Street view, Bloomberg owns the spread.

Who this is for: corporate development teams, private equity deal teams, event-driven and merger-arb analysts, and generalist buy-side analysts forming a view the morning a deal is announced.

Published August 20, 2026. Last reviewed August 21, 2026. Written by the AllMind AI research team.

Disclosure: AllMind AI builds one of the platforms compared here. Rival screeners are credited where their coverage or filters are stronger, and no vendor paid to appear.

Key takeaways

• Screening and analysis are two jobs. Screening is a universe-and-ranking problem the deal databases own. Analysis is long multi-source work across filings, estimates, research and relationships.
• Private-target universes belong to the deal databases. Grata advertises 22M+ company profiles and 800K+ historical transactions; Mergermarket advertises 1.4 million profiles and predictive signals on sponsor exits expected within 6 to 18 months, per their sites in August 2026.
• Public-deal analysis needs one connected corpus. Terms, premium, multiples paid, synergy checks, precedents and supplier overlap come from filings, estimate feeds, entitled research and relationship data at once.
• AI's failure modes here are checkable. Invented precedents, the wrong share count and estimates dressed as reported figures cause most bad deal memos; source-level traceability catches all three.
• The backdrop rewards mid-market screening. Global M&A value rose about 40% in 2025 to roughly $4.9 trillion per Bain & Company, but megadeals drove the gain while deal count fell.

What are the best AI tools for M&A target screening and analysis in 2026?

For the analysis half, the long work of pricing a deal on public companies, AllMind AI is the answer, because the two companies, their segments, their suppliers and customers, their estimates and your own deal files sit on one map an agent can traverse. The screening half belongs to the deal databases: PitchBook, S&P Capital IQ, Mergermarket, Grata. Document and deliverable layers turn a room or a live process into output: Hebbia, Rogo and the general assistants. Bloomberg carries the spread. No product is best at both halves, and buying as if one were leaves you with a stale screen or a memo with no precedents.

How we evaluated the M&A tools

Four questions decide whether a tool survives a deal team's first live use:

• How much of the universe does it cover: public, sponsor-backed, founder-owned?
• Do its numbers link back to a filing or a transaction record?
• Can it read what you bring, and hold your own files alongside it?
• Does it ship the deliverable, or an answer in a box?

Who is screening: corporate development, private equity or public investors?

Three groups screen with AI and want different things: corporate development wants strategic fit and a short list, private equity wants a refreshed universe with timing signals, and public-equity investors are rarely screening at all.

• Corporate development teams start from strategy: overlap on customers, suppliers and products, a few precedents, a board-ready page per target. An entity map plus Capital IQ covers most of it; Grata adds the founder-owned names.
• Private equity and search funds live in the universe: PitchBook, Grata and Mergermarket daily, Hebbia once a room opens.
• Event-driven and merger-arb desks need the agreement parsed, the premium set against precedents, the overlap mapped.
• Generalist analysts covering an acquirer need the note by the open: accretion math, synergy credibility, the balance sheet after close.

The nine specialist AI tools for M&A target screening and analysis, reviewed

The nine dedicated platforms, in the order a deal team reaches for them.

1. AllMind AI

AllMind AI is the deal-side system in this list. It holds 6,800+ premium datasets, 750 million+ documents and a firm's own deal files on one map of companies, segments, suppliers, customers, estimates and filings, with agents working across it.

Where it wins: the analysis half, where a question runs long and crosses sources. Both companies already sit on the map as linked entities, so nobody assembles the file first, and what hangs off them covers the classes a deal note needs:

• S&P, FactSet, LSEG and MSCI content for fundamentals, consensus and index treatment after close.
• SEC and SEDAR filings, the merger agreement, global investor-relations material for a non-US party.
• Earnings and financials on the tape within minutes, so a print inside the deal window moves the accretion math that morning.
• Expert Insights transcripts, included in the subscription and covering operators from either company, alongside broker research under the firm's entitlement.
• Sector and alternative data, mining and healthcare included, where value turns on reserve life or reimbursement instead of a revenue multiple.

Then the half that decides whether any of it is useful: your own material. A pipeline in a CRM, a target tracker in Snowflake, Databricks or S3 read where it sits under a scoped IAM role, an internal dashboard, the valuation model, the file from an approach made three years ago. Whatever the firm can expose gets joined to the external corpus, so the screen and the pipeline stop drifting apart.

The ontology is why the combination pays. Relationships are stored, so an agent traverses them: target to disclosed customers, those customers to the acquirer's disclosures on the other side, to the segment carrying the overlap, to the broker who modeled it. Regulatory and synergy sections get built by following links instead of keyword-matching a pile of documents, on the graph described in our guide to AI for supply chain analysis in equity research.

This is bought for work that runs long. Pricing a deal properly is an agent moving for hours, sometimes across days, through the agreement, both filing histories, the precedent set, the estimate revisions and the expert calls. Bank teams, hedge funds and Fortune 500 corporate development groups run it that way, some having folded a screening seat and a document tool into it. Agent Studio holds the standing version. Entitlements follow the person asking and agents cannot widen them, which matters when half a deal team is wall-crossed. Our June 2026 State of M&A report is the public sample.

Where it falls short: it is not a deal database. Private-company and transaction records arrive through partners, so a founder-owned universe or a two-decade precedent screen by sub-sector starts with Grata or Capital IQ. It is not a trading terminal either, so the live arb spread stays on Bloomberg. Head-to-heads: AllMind AI vs Hebbia and AllMind AI vs Rogo.

2. PitchBook

PitchBook, owned by Morningstar, is the private-market platform most sponsors open first: company, deal, fund, investor and people records with AI-assisted search.

Where it wins: sponsor-backed and venture-backed universes, fund and LP mapping, and the who-owns-what question that decides whether a target can transact at all.

Where it falls short: it finds and profiles companies. Public-company fundamentals run thinner than a terminal's, and document analysis happens elsewhere.

3. S&P Capital IQ

S&P Capital IQ is the deal-comps standard: public and private financials, a transaction database going back two decades, and Excel-native comps that banking and corp dev templates are built on.

Where it wins: precedent transactions. What similar assets sold for, at what multiple and premium, tagged consistently across the full history.

Where it falls short: no route to run AI over your own documents, real-time data costs extra, and the workflow is still the terminal and the Excel plug-in. Full comparison: AllMind AI vs Capital IQ.

4. Mergermarket (ION Analytics)

Mergermarket, a service of ION Analytics, is forward-looking M&A intelligence: 300+ journalists reporting on processes before announcement, plus predictive analytics on sponsor-backed companies likely to come to market within 6 to 18 months, per its site in August 2026.

Where it wins: timing. Knowing a sponsor is preparing an exit months before the teaser lands beats any screen a corporate acquirer could run.

Where it falls short: it is a feed. It will not model the target, read your data room or draft the approach memo.

5. Grata (joining with Sourcescrub)

Grata is a private-company search platform for deal sourcing, joining forces with Sourcescrub per its site in August 2026. It advertises 22M+ profiles including bootstrapped and founder-owned businesses, 800K+ historical transactions, and seller-intent signals 6 to 12 months before a process.

Where it wins: the long tail. Founder-owned businesses with no sponsor and no filings are invisible to a terminal and central to lower-mid-market theses.

Where it falls short: financials on most of those companies are estimates, and there is no public-markets role. Pricing is demo-led.

6. Hebbia

Hebbia does document analysis at scale, its Matrix grids running structured questions across very large sets, with strong adoption in private equity, credit and banking; its site cites firms with about $30 trillion of AUM and 1.5 billion pages processed in August 2026.

Where it wins: once the data room opens. Forty diligence questions across 3,000 documents, cited grid back, is what Matrix was built for. See also the best AI tools for private equity due diligence.

Where it falls short: Hebbia brings little market or transaction data of its own, so the universe is whatever you load, and screening and public comps come from the databases around it.

7. Rogo

Rogo is an AI analyst for banking and private equity deliverables: pitch books, CIM drafts, profiles and comps in banker formats. It announced a $160 million Series D led by Kleiner Perkins on April 29, 2026, a round Bloomberg and others reported at about a $2 billion valuation, though the announcement names none.

Where it wins: a sell-side or sponsor team that ships decks. Output lands near house style with less editing than a general assistant.

Where it falls short: a process starts and ends, and so does Rogo's usefulness on a name. Following the acquirer for eight more quarters is a coverage job it is not shaped around.

8. AlphaSense

AlphaSense searches broker research, filings, news and a publicly reported 280,000+ expert transcripts, with agentic features since 2025 and funding announced by the company at about a $7.5B valuation in June 2026.

Where it wins: the day after announcement, when you want every broker's take on the premium, the synergy math and the regulatory odds, plus expert calls from either side.

Where it falls short: it searches and summarizes. The two companies are documents in an index, not linked entities, and no pro forma results.

9. Bloomberg Terminal

Bloomberg Terminal, publicly reported at roughly $30,000 to $32,000 per seat for 2026, is where merger-arb desks watch the spread, run deal screens and message counterparties, with AskB as the assistant.

Where it wins: anything live. Spread, implied probability, financing color and the chat with the desk across the street.

Where it falls short: AskB works over terminal content and stays there, so the agreement you downloaded, the data room and your model are out of reach.

How do you screen M&A targets with AI, step by step?

Screening with AI is a five-step loop: thesis as explicit criteria, a universe from the right database, enrichment per name, agent scoring with citations, then triage with the rest under watch. Steps three and four replace weeks of reading and tagging. The table below is the artifact; copy it and set your thresholds.

1. Write the thesis as criteria. Sector and adjacency, geography, size range, ownership type, growth and margin floor, the strategic reason you would pay. Vague criteria produce a list nobody trusts.
2. Build the universe. Public targets from a fundamentals screen; sponsor-backed from PitchBook or Capital IQ; founder-owned from Grata; likely sellers from Mergermarket.
3. Enrich each name. Revenue and EBITDA labeled reported or estimated, ownership and hold period, capital structure and change-of-control terms, supplier and customer overlap with you.
4. Score and rank with citations. An agent applies the criteria, writes a one-line rationale per name and links each figure to its source, so a reviewer can reject a score in seconds.
5. Triage and watch. The short list gets a one-pager and an approach plan. The rest goes under monitoring: a sponsor past year five, a founder succession, a covenant breach, an activist filing.

How do you analyze an announced deal with AI?

Analyzing an announced deal runs in a fixed order: terms, economics, precedents, regulatory read, market view. This is the long-running part of the job, an agent working the agreement and the 8-K, building the pro forma from both filing histories and the estimate feeds, then drafting. The spread stays on the terminal.

• Terms from the documents. Consideration mix, exchange ratio and collar, termination fees both ways, go-shop window, MAE definition, outside date, each lifted from the agreement with its passage cited.
• Acquirer and target economics. Premium to the unaffected price, multiples paid on reported and consensus numbers, accretion or dilution, leverage at close. The synergy claim gets tested against segment data and what comparable acquirers delivered.
• Precedent transactions. Closest deals by sub-sector and size, what they paid, how long they took, pulled from Capital IQ and reconciled to the filings.
• Regulatory read. Where the two overlap on customers, suppliers and product markets, which agencies review, what happened in prior reviews of similar overlaps.
• Market view and second-order effects. Which brokers moved targets, what expert calls say about integration risk, which suppliers, customers and competitors are exposed. An entity map earns its place here.
• Spread and probability. Implied odds of closing, downside to the unaffected price, financing risk, written in as a dated snapshot.

Three failure modes account for most bad deal memos:

• Invented precedents. General assistants name deals that did not happen at multiples never paid. A precedent with no record behind it is not a precedent.
• The wrong share count. Basic versus diluted, treasury-method options and convertibles move enterprise value enough to flip an accretion call. The arithmetic has to be visible.
• Estimates presented as facts. Private-company revenue from a database is an estimate and should be labeled as one in every table it touches.

Can ChatGPT or Claude do M&A target screening and analysis?

Partly. They turn a rough thesis into crisp criteria, summarize a CIM you paste in, explain a clause and sanity-check a pro forma, and deal teams use them for that daily. They cannot hold a target universe, pull entitled financials, link a number to its filing, or leave an audit trail. Asked for a target list or a precedent table, they return confident entries, some invented.

Keep them at the edges and keep the screen where numbers have to be defended. Corporate teams can start from the AllMind AI corporates page and the data coverage behind it.

Frequently Asked Questions

What are the best AI tools for M&A target screening and analysis?

For analyzing a live or likely deal between public companies, AllMind AI is the strongest pick, because both sides sit on one map with their filings, estimates, entitled broker research and their supplier and customer links, so an agent can work the whole file for hours with every figure tracing to source. For building a private target universe the deal databases lead: Grata for founder-owned companies, PitchBook and S&P Capital IQ for sponsor-backed names and precedents, Mergermarket for who is likely to sell. Hebbia covers data-room diligence and Rogo covers banker deliverables.

Can AI find acquisition targets that are not for sale?

Yes, within limits. Grata advertises seller-intent signals 6 to 12 months before a competitive process, and Mergermarket sells predictive analytics on sponsor-backed companies expected to come to market within 6 to 18 months, both as of August 2026. Those are probabilities built from hiring, ownership and hold-period patterns, so treat them as a prioritized call list, not a confirmed process.

How do public-equity investors use AI to analyze an announced acquisition?

They pull terms from the merger agreement and the 8-K, compute the premium and multiples paid against precedents, test the synergy claim against segment data, and map where the two overlap on customers and suppliers for the regulatory read. The live spread and implied deal probability still come from a terminal. The AI's job is the memo, every number linked back to its document.

Is PitchBook or Capital IQ better for M&A target screening?

PitchBook is usually the better start for sponsor-backed and venture-backed targets, fund mapping and investor relationships. S&P Capital IQ is stronger on precedent transactions, public comps and Excel-native modeling, and its Excel plug-in pulls a comp set straight into a deal model. Many teams hold both and add Grata or Mergermarket for founder-owned names and forward-looking intelligence.

Can ChatGPT screen M&A targets?

ChatGPT and Claude draft screening criteria, summarize pasted documents and sanity-check a model, but hold no deal database, no entitled financials and no audit trail. Asked for precedent transactions or a target list, they produce plausible names and multiples that are sometimes invented. Use them at the edges and keep the screen itself where numbers trace to a source.

AllMind AI is the AI-native research platform for institutional equity teams. If you want proof on your own work, send us the workflow you want tested.